SUBSCRIBE
SUBSCRIBE

Decibel Therapeutics

NEWS
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
 · 
11 min read
 · 
Mark Terry
What You Need to Know About Decibel Therapeutics
Business
What You Need to Know About Decibel Therapeutics
January 3, 2017
 · 
3 min read
Year-Old Startup Decibel Therapeutics Inks Lease for Huge New HQ in Boston
Business
Year-Old Startup Decibel Therapeutics Inks Lease for Huge New HQ in Boston
August 4, 2016
 · 
2 min read
Business
Former Biogen Exec to Head Decibel Therapeutics, Plans to Fill 20 Jobs This Year, 40 to 60 in 2017
July 13, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Third Rock Ventures and GlaxoSmithKline’s SR One Launch Decibel Therapeutics With $52 Million, Expect to Hire 50-60 By Year End
October 15, 2015
 · 
3 min read
Load More
AWARDS
  • NextGen Class of 2017
JOBS
IN THE PRESS
Genetown
Decibel Therapeutics to Participate in the Upcoming Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days
March 28, 2023
 · 
1 min read
Business
Decibel Therapeutics Appoints Matthew Kapusta to its Board of Directors
March 21, 2023
 · 
5 min read
Business
Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
March 14, 2023
 · 
10 min read
Genetown
Decibel Therapeutics to Present at the Upcoming SVB Securities Global Biopharma Conference
February 16, 2023
 · 
1 min read
Genetown
Decibel Therapeutics to Present at the 46th Annual Association for Research in Otolaryngology (ARO) MidWinter Meeting
February 9, 2023
 · 
2 min read
Drug Development
Decibel Therapeutics Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Lead Gene Therapy Candidate DB-OTO
January 24, 2023
 · 
6 min read
Business
Decibel Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Update
November 9, 2022
 · 
8 min read
Genetown
Decibel Therapeutics Announces Submission of Clinical Trial Applications for Lead Gene Therapy Candidate DB-OTO
November 2, 2022
 · 
5 min read
Drug Development
Decibel Therapeutics Receives FDA Clearance of IND Application for DB-OTO, a Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin-Related Hearing Loss
October 17, 2022
 · 
8 min read
Genetown
Decibel Therapeutics to Participate in the Jefferies Cell and Genetic Medicine Summit
September 22, 2022
 · 
1 min read
Load More